nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—uterine cancer	0.443	1	CbGaD
Arsenic trioxide—CYP1B1—Progesterone—uterine cancer	0.0979	0.313	CbGbCtD
Arsenic trioxide—CYP1A1—Progesterone—uterine cancer	0.043	0.137	CbGbCtD
Arsenic trioxide—CYP1B1—Doxorubicin—uterine cancer	0.0299	0.0956	CbGbCtD
Arsenic trioxide—ABCC2—Carboplatin—uterine cancer	0.0274	0.0878	CbGbCtD
Arsenic trioxide—ABCC2—Etoposide—uterine cancer	0.023	0.0737	CbGbCtD
Arsenic trioxide—ABCB1—Progesterone—uterine cancer	0.0168	0.0537	CbGbCtD
Arsenic trioxide—ABCC2—Doxorubicin—uterine cancer	0.0157	0.0503	CbGbCtD
Arsenic trioxide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0152	0.0486	CbGbCtD
Arsenic trioxide—ABCB1—Dactinomycin—uterine cancer	0.0133	0.0426	CbGbCtD
Arsenic trioxide—CYP3A4—Progesterone—uterine cancer	0.0101	0.0322	CbGbCtD
Arsenic trioxide—ABCB1—Etoposide—uterine cancer	0.00751	0.024	CbGbCtD
Arsenic trioxide—ABCB1—Doxorubicin—uterine cancer	0.00512	0.0164	CbGbCtD
Arsenic trioxide—CYP3A4—Etoposide—uterine cancer	0.0045	0.0144	CbGbCtD
Arsenic trioxide—CYP3A4—Doxorubicin—uterine cancer	0.00307	0.00982	CbGbCtD
Arsenic trioxide—JUN—oviduct—uterine cancer	0.00279	0.0317	CbGeAlD
Arsenic trioxide—CCND1—exocrine gland—uterine cancer	0.00263	0.0299	CbGeAlD
Arsenic trioxide—MAPK3—artery—uterine cancer	0.00225	0.0256	CbGeAlD
Arsenic trioxide—AKT1—artery—uterine cancer	0.00212	0.0241	CbGeAlD
Arsenic trioxide—MAPK3—exocrine gland—uterine cancer	0.00196	0.0223	CbGeAlD
Arsenic trioxide—AKT1—exocrine gland—uterine cancer	0.00185	0.021	CbGeAlD
Arsenic trioxide—JUN—artery—uterine cancer	0.00185	0.021	CbGeAlD
Arsenic trioxide—JUN—exocrine gland—uterine cancer	0.00161	0.0183	CbGeAlD
Arsenic trioxide—CCND1—myometrium—uterine cancer	0.00146	0.0166	CbGeAlD
Arsenic trioxide—CCND1—epithelium—uterine cancer	0.00114	0.013	CbGeAlD
Arsenic trioxide—TXNRD1—myometrium—uterine cancer	0.00114	0.013	CbGeAlD
Arsenic trioxide—CCND1—uterine cervix—uterine cancer	0.00113	0.0129	CbGeAlD
Arsenic trioxide—CCND1—smooth muscle tissue—uterine cancer	0.0011	0.0125	CbGeAlD
Arsenic trioxide—MAPK3—myometrium—uterine cancer	0.00109	0.0123	CbGeAlD
Arsenic trioxide—CCND1—decidua—uterine cancer	0.00108	0.0123	CbGeAlD
Arsenic trioxide—CCND1—renal system—uterine cancer	0.00106	0.0121	CbGeAlD
Arsenic trioxide—CCND1—endometrium—uterine cancer	0.00103	0.0117	CbGeAlD
Arsenic trioxide—AKT1—myometrium—uterine cancer	0.00102	0.0116	CbGeAlD
Arsenic trioxide—CCND1—mammalian vulva—uterine cancer	0.000992	0.0113	CbGeAlD
Arsenic trioxide—MAPK1—epithelium—uterine cancer	0.000964	0.0109	CbGeAlD
Arsenic trioxide—MAPK1—uterine cervix—uterine cancer	0.000955	0.0109	CbGeAlD
Arsenic trioxide—CCND1—uterus—uterine cancer	0.000945	0.0107	CbGeAlD
Arsenic trioxide—MAPK1—smooth muscle tissue—uterine cancer	0.000928	0.0105	CbGeAlD
Arsenic trioxide—MAPK1—decidua—uterine cancer	0.00091	0.0103	CbGeAlD
Arsenic trioxide—TXNRD1—epithelium—uterine cancer	0.000897	0.0102	CbGeAlD
Arsenic trioxide—MAPK1—renal system—uterine cancer	0.000894	0.0102	CbGeAlD
Arsenic trioxide—JUN—myometrium—uterine cancer	0.000892	0.0101	CbGeAlD
Arsenic trioxide—TXNRD1—uterine cervix—uterine cancer	0.000889	0.0101	CbGeAlD
Arsenic trioxide—IKBKB—myometrium—uterine cancer	0.000888	0.0101	CbGeAlD
Arsenic trioxide—TXNRD1—smooth muscle tissue—uterine cancer	0.000864	0.00982	CbGeAlD
Arsenic trioxide—MAPK3—epithelium—uterine cancer	0.000853	0.00969	CbGeAlD
Arsenic trioxide—CCND1—female reproductive system—uterine cancer	0.000849	0.00965	CbGeAlD
Arsenic trioxide—TXNRD1—decidua—uterine cancer	0.000847	0.00963	CbGeAlD
Arsenic trioxide—MAPK3—uterine cervix—uterine cancer	0.000845	0.00961	CbGeAlD
Arsenic trioxide—MAPK1—mammalian vulva—uterine cancer	0.000836	0.0095	CbGeAlD
Arsenic trioxide—TXNRD1—renal system—uterine cancer	0.000832	0.00945	CbGeAlD
Arsenic trioxide—MAPK3—smooth muscle tissue—uterine cancer	0.000822	0.00934	CbGeAlD
Arsenic trioxide—MAPK3—decidua—uterine cancer	0.000806	0.00915	CbGeAlD
Arsenic trioxide—TXNRD1—endometrium—uterine cancer	0.000804	0.00914	CbGeAlD
Arsenic trioxide—AKT1—epithelium—uterine cancer	0.000804	0.00914	CbGeAlD
Arsenic trioxide—AKT1—uterine cervix—uterine cancer	0.000797	0.00906	CbGeAlD
Arsenic trioxide—MAPK1—uterus—uterine cancer	0.000796	0.00905	CbGeAlD
Arsenic trioxide—MAPK3—renal system—uterine cancer	0.000791	0.00899	CbGeAlD
Arsenic trioxide—TXNRD1—mammalian vulva—uterine cancer	0.000778	0.00884	CbGeAlD
Arsenic trioxide—AKT1—smooth muscle tissue—uterine cancer	0.000775	0.0088	CbGeAlD
Arsenic trioxide—CCND1—female gonad—uterine cancer	0.000773	0.00878	CbGeAlD
Arsenic trioxide—CCND1—vagina—uterine cancer	0.000768	0.00873	CbGeAlD
Arsenic trioxide—MAPK3—endometrium—uterine cancer	0.000765	0.00869	CbGeAlD
Arsenic trioxide—AKT1—decidua—uterine cancer	0.00076	0.00863	CbGeAlD
Arsenic trioxide—AKT1—renal system—uterine cancer	0.000746	0.00848	CbGeAlD
Arsenic trioxide—TXNRD1—uterus—uterine cancer	0.000741	0.00842	CbGeAlD
Arsenic trioxide—MAPK3—mammalian vulva—uterine cancer	0.00074	0.0084	CbGeAlD
Arsenic trioxide—AKT1—endometrium—uterine cancer	0.000721	0.00819	CbGeAlD
Arsenic trioxide—MAPK1—female reproductive system—uterine cancer	0.000716	0.00813	CbGeAlD
Arsenic trioxide—MAPK3—uterus—uterine cancer	0.000705	0.00801	CbGeAlD
Arsenic trioxide—JUN—epithelium—uterine cancer	0.0007	0.00795	CbGeAlD
Arsenic trioxide—AKT1—mammalian vulva—uterine cancer	0.000698	0.00793	CbGeAlD
Arsenic trioxide—JUN—uterine cervix—uterine cancer	0.000694	0.00789	CbGeAlD
Arsenic trioxide—IKBKB—uterine cervix—uterine cancer	0.000691	0.00785	CbGeAlD
Arsenic trioxide—JUN—smooth muscle tissue—uterine cancer	0.000674	0.00766	CbGeAlD
Arsenic trioxide—IKBKB—smooth muscle tissue—uterine cancer	0.000671	0.00763	CbGeAlD
Arsenic trioxide—TXNRD1—female reproductive system—uterine cancer	0.000666	0.00757	CbGeAlD
Arsenic trioxide—AKT1—uterus—uterine cancer	0.000665	0.00755	CbGeAlD
Arsenic trioxide—JUN—decidua—uterine cancer	0.000661	0.00751	CbGeAlD
Arsenic trioxide—IKBKB—decidua—uterine cancer	0.000658	0.00748	CbGeAlD
Arsenic trioxide—MAPK1—female gonad—uterine cancer	0.000651	0.0074	CbGeAlD
Arsenic trioxide—JUN—renal system—uterine cancer	0.000649	0.00738	CbGeAlD
Arsenic trioxide—MAPK1—vagina—uterine cancer	0.000647	0.00736	CbGeAlD
Arsenic trioxide—MAPK3—female reproductive system—uterine cancer	0.000633	0.0072	CbGeAlD
Arsenic trioxide—JUN—endometrium—uterine cancer	0.000628	0.00713	CbGeAlD
Arsenic trioxide—IKBKB—endometrium—uterine cancer	0.000625	0.0071	CbGeAlD
Arsenic trioxide—JUN—mammalian vulva—uterine cancer	0.000607	0.0069	CbGeAlD
Arsenic trioxide—TXNRD1—female gonad—uterine cancer	0.000606	0.00689	CbGeAlD
Arsenic trioxide—IKBKB—mammalian vulva—uterine cancer	0.000604	0.00687	CbGeAlD
Arsenic trioxide—TXNRD1—vagina—uterine cancer	0.000603	0.00685	CbGeAlD
Arsenic trioxide—AKT1—female reproductive system—uterine cancer	0.000597	0.00679	CbGeAlD
Arsenic trioxide—TXNRD1—Teniposide—Etoposide—uterine cancer	0.000585	0.192	CbGdCrCtD
Arsenic trioxide—JUN—uterus—uterine cancer	0.000578	0.00657	CbGeAlD
Arsenic trioxide—MAPK3—female gonad—uterine cancer	0.000576	0.00655	CbGeAlD
Arsenic trioxide—IKBKB—uterus—uterine cancer	0.000576	0.00654	CbGeAlD
Arsenic trioxide—MAPK3—vagina—uterine cancer	0.000573	0.00651	CbGeAlD
Arsenic trioxide—AKT1—female gonad—uterine cancer	0.000544	0.00618	CbGeAlD
Arsenic trioxide—AKT1—vagina—uterine cancer	0.00054	0.00614	CbGeAlD
Arsenic trioxide—JUN—female reproductive system—uterine cancer	0.00052	0.00591	CbGeAlD
Arsenic trioxide—IKBKB—female reproductive system—uterine cancer	0.000517	0.00588	CbGeAlD
Arsenic trioxide—CCND1—lymph node—uterine cancer	0.000497	0.00565	CbGeAlD
Arsenic trioxide—JUN—female gonad—uterine cancer	0.000473	0.00538	CbGeAlD
Arsenic trioxide—IKBKB—female gonad—uterine cancer	0.000471	0.00535	CbGeAlD
Arsenic trioxide—JUN—vagina—uterine cancer	0.00047	0.00534	CbGeAlD
Arsenic trioxide—IKBKB—vagina—uterine cancer	0.000468	0.00532	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Medroxyprogesterone Acetate—uterine cancer	0.000425	0.14	CbGdCrCtD
Arsenic trioxide—MAPK1—lymph node—uterine cancer	0.000419	0.00476	CbGeAlD
Arsenic trioxide—TXNRD1—lymph node—uterine cancer	0.00039	0.00443	CbGeAlD
Arsenic trioxide—TXNRD1—Testosterone—Progesterone—uterine cancer	0.000371	0.122	CbGdCrCtD
Arsenic trioxide—MAPK3—lymph node—uterine cancer	0.000371	0.00421	CbGeAlD
Arsenic trioxide—CYP1B1—smooth muscle tissue—uterine cancer	0.00036	0.00409	CbGeAlD
Arsenic trioxide—ABCC2—renal system—uterine cancer	0.000353	0.00402	CbGeAlD
Arsenic trioxide—CYP1B1—decidua—uterine cancer	0.000352	0.00401	CbGeAlD
Arsenic trioxide—AKT1—lymph node—uterine cancer	0.000349	0.00397	CbGeAlD
Arsenic trioxide—CYP1B1—renal system—uterine cancer	0.000346	0.00393	CbGeAlD
Arsenic trioxide—CYP1B1—uterus—uterine cancer	0.000308	0.0035	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Epirubicin—uterine cancer	0.000305	0.1	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Epirubicin—uterine cancer	0.000305	0.1	CbGdCrCtD
Arsenic trioxide—JUN—lymph node—uterine cancer	0.000304	0.00346	CbGeAlD
Arsenic trioxide—IKBKB—lymph node—uterine cancer	0.000303	0.00344	CbGeAlD
Arsenic trioxide—ABCC2—female reproductive system—uterine cancer	0.000283	0.00322	CbGeAlD
Arsenic trioxide—TXNRD1—Idarubicin—Doxorubicin—uterine cancer	0.000282	0.0928	CbGdCrCtD
Arsenic trioxide—TXNRD1—Daunorubicin—Doxorubicin—uterine cancer	0.000282	0.0928	CbGdCrCtD
Arsenic trioxide—CYP1B1—female reproductive system—uterine cancer	0.000277	0.00315	CbGeAlD
Arsenic trioxide—TXNRD1—Norethindrone—Progesterone—uterine cancer	0.000271	0.0891	CbGdCrCtD
Arsenic trioxide—CYP1A1—epithelium—uterine cancer	0.000264	0.003	CbGeAlD
Arsenic trioxide—CYP1A1—uterine cervix—uterine cancer	0.000262	0.00297	CbGeAlD
Arsenic trioxide—CYP1B1—female gonad—uterine cancer	0.000252	0.00287	CbGeAlD
Arsenic trioxide—CYP1A1—renal system—uterine cancer	0.000245	0.00278	CbGeAlD
Arsenic trioxide—CYP1A1—mammalian vulva—uterine cancer	0.000229	0.0026	CbGeAlD
Arsenic trioxide—CYP1A1—uterus—uterine cancer	0.000218	0.00248	CbGeAlD
Arsenic trioxide—TXNRD1—Levonorgestrel—Progesterone—uterine cancer	0.000216	0.0709	CbGdCrCtD
Arsenic trioxide—CYP1A1—female reproductive system—uterine cancer	0.000196	0.00223	CbGeAlD
Arsenic trioxide—CYP3A4—renal system—uterine cancer	0.00018	0.00204	CbGeAlD
Arsenic trioxide—CYP1A1—female gonad—uterine cancer	0.000178	0.00203	CbGeAlD
Arsenic trioxide—CYP1A1—vagina—uterine cancer	0.000177	0.00201	CbGeAlD
Arsenic trioxide—ABCB1—myometrium—uterine cancer	0.000175	0.00198	CbGeAlD
Arsenic trioxide—ABCC2—lymph node—uterine cancer	0.000166	0.00188	CbGeAlD
Arsenic trioxide—CYP1B1—lymph node—uterine cancer	0.000162	0.00184	CbGeAlD
Arsenic trioxide—CYP3A4—female reproductive system—uterine cancer	0.000144	0.00163	CbGeAlD
Arsenic trioxide—ABCB1—epithelium—uterine cancer	0.000137	0.00156	CbGeAlD
Arsenic trioxide—ABCB1—uterine cervix—uterine cancer	0.000136	0.00154	CbGeAlD
Arsenic trioxide—ABCB1—decidua—uterine cancer	0.000129	0.00147	CbGeAlD
Arsenic trioxide—ABCB1—renal system—uterine cancer	0.000127	0.00144	CbGeAlD
Arsenic trioxide—ABCB1—endometrium—uterine cancer	0.000123	0.0014	CbGeAlD
Arsenic trioxide—ABCB1—mammalian vulva—uterine cancer	0.000119	0.00135	CbGeAlD
Arsenic trioxide—CYP1A1—lymph node—uterine cancer	0.000115	0.0013	CbGeAlD
Arsenic trioxide—ABCB1—uterus—uterine cancer	0.000113	0.00129	CbGeAlD
Arsenic trioxide—ABCB1—female reproductive system—uterine cancer	0.000102	0.00116	CbGeAlD
Arsenic trioxide—ABCB1—female gonad—uterine cancer	9.26e-05	0.00105	CbGeAlD
Arsenic trioxide—ABCB1—vagina—uterine cancer	9.21e-05	0.00105	CbGeAlD
Arsenic trioxide—ABCB1—lymph node—uterine cancer	5.95e-05	0.000677	CbGeAlD
Arsenic trioxide—AKT1—Immune System—ERBB2—uterine cancer	4.36e-06	2.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FGFR2—uterine cancer	4.35e-06	2.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—HRAS—uterine cancer	4.35e-06	2.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SMAD3—uterine cancer	4.34e-06	2.83e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—HRAS—uterine cancer	4.33e-06	2.83e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—KRAS—uterine cancer	4.33e-06	2.82e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—PIK3CA—uterine cancer	4.32e-06	2.82e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.31e-06	2.81e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—MTHFR—uterine cancer	4.29e-06	2.8e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—HRAS—uterine cancer	4.27e-06	2.78e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB2—uterine cancer	4.23e-06	2.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—uterine cancer	4.21e-06	2.75e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CDKN1B—uterine cancer	4.2e-06	2.74e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—RRM2—uterine cancer	4.18e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—CXCL8—uterine cancer	4.17e-06	2.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—HRAS—uterine cancer	4.16e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—PIK3CA—uterine cancer	4.15e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—KRAS—uterine cancer	4.15e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SMAD3—uterine cancer	4.15e-06	2.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FGFR2—uterine cancer	4.14e-06	2.7e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—DCN—uterine cancer	4.05e-06	2.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—HRAS—uterine cancer	4.04e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—AKT1—uterine cancer	4.04e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CDKN1B—uterine cancer	4.04e-06	2.63e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB2—uterine cancer	4.02e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB2—uterine cancer	4.02e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—KRAS—uterine cancer	4.02e-06	2.62e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—HRAS—uterine cancer	4e-06	2.61e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ESR1—uterine cancer	4e-06	2.6e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—PIK3CA—uterine cancer	3.97e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CTNNB1—uterine cancer	3.97e-06	2.59e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FGFR2—uterine cancer	3.96e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—AKT1—uterine cancer	3.96e-06	2.58e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1B1—uterine cancer	3.93e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—STAR—uterine cancer	3.93e-06	2.56e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CDKN1B—uterine cancer	3.91e-06	2.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB2—uterine cancer	3.9e-06	2.54e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PTEN—uterine cancer	3.87e-06	2.52e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB2—uterine cancer	3.85e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—HRAS—uterine cancer	3.84e-06	2.51e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—AKT1—uterine cancer	3.84e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ESR1—uterine cancer	3.84e-06	2.5e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—AKT1—uterine cancer	3.83e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP11A1—uterine cancer	3.82e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—PIK3CA—uterine cancer	3.82e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CTNNB1—uterine cancer	3.81e-06	2.49e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.78e-06	2.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—AKT1—uterine cancer	3.77e-06	2.46e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CDKN1B—uterine cancer	3.73e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CDKN1B—uterine cancer	3.72e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ESR1—uterine cancer	3.72e-06	2.43e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PTEN—uterine cancer	3.72e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB2—uterine cancer	3.71e-06	2.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CTNNB1—uterine cancer	3.7e-06	2.41e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—PIK3CA—uterine cancer	3.69e-06	2.41e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—EP300—uterine cancer	3.69e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—HRAS—uterine cancer	3.68e-06	2.4e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.64e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—NRAS—uterine cancer	3.63e-06	2.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CDKN1B—uterine cancer	3.61e-06	2.36e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKR1C3—uterine cancer	3.61e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PTEN—uterine cancer	3.6e-06	2.35e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—uterine cancer	3.57e-06	2.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—AKT1—uterine cancer	3.57e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CDKN1B—uterine cancer	3.56e-06	2.32e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—EP300—uterine cancer	3.54e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ESR1—uterine cancer	3.54e-06	2.31e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—HRAS—uterine cancer	3.53e-06	2.3e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CTNNB1—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—NRAS—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CTNNB1—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—STK11—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CYP19A1—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CCL2—uterine cancer	3.52e-06	2.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—NRAS—uterine cancer	3.45e-06	2.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CDKN1B—uterine cancer	3.44e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—EP300—uterine cancer	3.44e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PTEN—uterine cancer	3.43e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PTEN—uterine cancer	3.43e-06	2.24e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HRAS—uterine cancer	3.42e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CTNNB1—uterine cancer	3.41e-06	2.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—AKT1—uterine cancer	3.39e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ESR1—uterine cancer	3.39e-06	2.21e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CCL2—uterine cancer	3.38e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CTNNB1—uterine cancer	3.37e-06	2.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—NRAS—uterine cancer	3.35e-06	2.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PTEN—uterine cancer	3.33e-06	2.17e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—NRAS—uterine cancer	3.32e-06	2.16e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.3e-06	2.15e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PTEN—uterine cancer	3.28e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CCL2—uterine cancer	3.28e-06	2.14e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—EP300—uterine cancer	3.27e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—EP300—uterine cancer	3.27e-06	2.13e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CTNNB1—uterine cancer	3.25e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—AKT1—uterine cancer	3.25e-06	2.12e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—NRAS—uterine cancer	3.22e-06	2.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—EP300—uterine cancer	3.17e-06	2.07e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PTEN—uterine cancer	3.17e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—PIK3CA—uterine cancer	3.16e-06	2.06e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.15e-06	2.05e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—EP300—uterine cancer	3.13e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—KRAS—uterine cancer	3.12e-06	2.04e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CCL2—uterine cancer	3.12e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—AKT1—uterine cancer	3.12e-06	2.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—POLD1—uterine cancer	3.09e-06	2.01e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NRAS—uterine cancer	3.06e-06	2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—NRAS—uterine cancer	3.06e-06	1.99e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—KRAS—uterine cancer	3.03e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—EP300—uterine cancer	3.02e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AKT1—uterine cancer	3.02e-06	1.97e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CCL2—uterine cancer	2.98e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—KRAS—uterine cancer	2.97e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NRAS—uterine cancer	2.97e-06	1.94e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB2—uterine cancer	2.93e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—NRAS—uterine cancer	2.93e-06	1.91e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C1—uterine cancer	2.89e-06	1.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—KRAS—uterine cancer	2.88e-06	1.88e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTEN—uterine cancer	2.87e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—PIK3CA—uterine cancer	2.87e-06	1.87e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—KRAS—uterine cancer	2.85e-06	1.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NRAS—uterine cancer	2.82e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB2—uterine cancer	2.82e-06	1.84e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CYP19A1—uterine cancer	2.81e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—STK11—uterine cancer	2.81e-06	1.83e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—PIK3CA—uterine cancer	2.78e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CXCL8—uterine cancer	2.78e-06	1.81e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—KRAS—uterine cancer	2.77e-06	1.8e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—EP300—uterine cancer	2.74e-06	1.79e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB2—uterine cancer	2.73e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PIK3CA—uterine cancer	2.73e-06	1.78e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CDKN1B—uterine cancer	2.72e-06	1.77e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CXCL8—uterine cancer	2.67e-06	1.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—HRAS—uterine cancer	2.65e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—PIK3CA—uterine cancer	2.65e-06	1.73e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—MTHFR—uterine cancer	2.64e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—KRAS—uterine cancer	2.63e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—KRAS—uterine cancer	2.63e-06	1.72e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PIK3CA—uterine cancer	2.62e-06	1.71e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CDKN1B—uterine cancer	2.61e-06	1.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB2—uterine cancer	2.6e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CXCL8—uterine cancer	2.59e-06	1.69e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—HRAS—uterine cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—RRM2—uterine cancer	2.57e-06	1.68e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—CTNNB1—uterine cancer	2.57e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—KRAS—uterine cancer	2.56e-06	1.67e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PIK3CA—uterine cancer	2.54e-06	1.66e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CDKN1B—uterine cancer	2.53e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—HRAS—uterine cancer	2.52e-06	1.65e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—KRAS—uterine cancer	2.52e-06	1.64e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTEN—uterine cancer	2.5e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—DCN—uterine cancer	2.5e-06	1.63e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB2—uterine cancer	2.49e-06	1.62e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CXCL8—uterine cancer	2.47e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—CTNNB1—uterine cancer	2.47e-06	1.61e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—HRAS—uterine cancer	2.45e-06	1.6e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—KRAS—uterine cancer	2.43e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—HRAS—uterine cancer	2.43e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PIK3CA—uterine cancer	2.42e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PIK3CA—uterine cancer	2.42e-06	1.58e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CDKN1B—uterine cancer	2.41e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTEN—uterine cancer	2.4e-06	1.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—CTNNB1—uterine cancer	2.39e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTEN—uterine cancer	2.39e-06	1.56e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EP300—uterine cancer	2.38e-06	1.55e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CXCL8—uterine cancer	2.36e-06	1.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP11A1—uterine cancer	2.35e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—HRAS—uterine cancer	2.35e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PIK3CA—uterine cancer	2.35e-06	1.53e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTEN—uterine cancer	2.33e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.33e-06	1.52e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PIK3CA—uterine cancer	2.31e-06	1.51e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CDKN1B—uterine cancer	2.3e-06	1.5e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EP300—uterine cancer	2.29e-06	1.49e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—EP300—uterine cancer	2.28e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—CTNNB1—uterine cancer	2.27e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—uterine cancer	2.27e-06	1.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—VEGFA—uterine cancer	2.26e-06	1.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HRAS—uterine cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—HRAS—uterine cancer	2.24e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PIK3CA—uterine cancer	2.23e-06	1.46e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—NRAS—uterine cancer	2.23e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—uterine cancer	2.23e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKR1C3—uterine cancer	2.22e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EP300—uterine cancer	2.22e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTEN—uterine cancer	2.22e-06	1.45e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—CTNNB1—uterine cancer	2.18e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HRAS—uterine cancer	2.17e-06	1.42e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—VEGFA—uterine cancer	2.17e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—uterine cancer	2.16e-06	1.41e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—NRAS—uterine cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—HRAS—uterine cancer	2.14e-06	1.4e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTEN—uterine cancer	2.12e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EP300—uterine cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—MTHFR—uterine cancer	2.11e-06	1.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—VEGFA—uterine cancer	2.1e-06	1.37e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—NRAS—uterine cancer	2.08e-06	1.36e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—uterine cancer	2.08e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HRAS—uterine cancer	2.07e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—uterine cancer	2.07e-06	1.35e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PIK3CA—uterine cancer	2.03e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EP300—uterine cancer	2.02e-06	1.32e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—VEGFA—uterine cancer	2e-06	1.31e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—NRAS—uterine cancer	1.98e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—uterine cancer	1.98e-06	1.29e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—KRAS—uterine cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—uterine cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—VEGFA—uterine cancer	1.92e-06	1.25e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—NRAS—uterine cancer	1.89e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—uterine cancer	1.89e-06	1.23e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—KRAS—uterine cancer	1.84e-06	1.2e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—uterine cancer	1.82e-06	1.19e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—KRAS—uterine cancer	1.79e-06	1.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PIK3CA—uterine cancer	1.76e-06	1.15e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—STK11—uterine cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.73e-06	1.13e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—uterine cancer	1.71e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—KRAS—uterine cancer	1.7e-06	1.11e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PIK3CA—uterine cancer	1.7e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PIK3CA—uterine cancer	1.69e-06	1.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PIK3CA—uterine cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—uterine cancer	1.64e-06	1.07e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HRAS—uterine cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—KRAS—uterine cancer	1.63e-06	1.06e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—uterine cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HRAS—uterine cancer	1.57e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PIK3CA—uterine cancer	1.56e-06	1.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HRAS—uterine cancer	1.52e-06	9.91e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—uterine cancer	1.51e-06	9.86e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PIK3CA—uterine cancer	1.5e-06	9.76e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTEN—uterine cancer	1.47e-06	9.59e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—uterine cancer	1.45e-06	9.44e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HRAS—uterine cancer	1.45e-06	9.43e-06	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—uterine cancer	1.44e-06	9.39e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—EP300—uterine cancer	1.4e-06	9.14e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HRAS—uterine cancer	1.38e-06	9.03e-06	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—uterine cancer	1.38e-06	8.97e-06	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—uterine cancer	1.34e-06	8.75e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—MTHFR—uterine cancer	1.3e-06	8.48e-06	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—uterine cancer	1.28e-06	8.33e-06	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—uterine cancer	1.22e-06	7.97e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTEN—uterine cancer	1.17e-06	7.66e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—EP300—uterine cancer	1.12e-06	7.3e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PIK3CA—uterine cancer	1.04e-06	6.76e-06	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—uterine cancer	8.48e-07	5.53e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PIK3CA—uterine cancer	8.29e-07	5.4e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTEN—uterine cancer	7.24e-07	4.72e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—EP300—uterine cancer	6.9e-07	4.5e-06	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—uterine cancer	6.77e-07	4.41e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PIK3CA—uterine cancer	5.11e-07	3.33e-06	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—uterine cancer	4.17e-07	2.72e-06	CbGpPWpGaD
